Background: A need to develop therapeutics to treat Ebola virus disease patients in remote and resource-challenged settings remains in the wake of the 2013-2016 epidemic in West Africa. Toward this goal, we screened drugs under consideration as treatment options and other drugs of interest, most being small molecules approved by the Food and Drug Administration. Drugs demonstrating in vitro antiviral activity were advanced for evaluation in combinations because of advantages often provided by drug cocktails. Methods: Drugs were screened for blockade of Ebola virus infection in cultured cells. Twelve drugs were tested in all (78 pair-wise) combinations, and 3 were tested in a subset of combinations. Results: Multiple synergistic drug pairs emerged, with the majority comprising 2 entry inhibitors. For the pairs of entry inhibitors studied, synergy was demonstrated at the level of virus entry into host cells. Highly synergistic pairs included aripiprazole/piperacetazine, sertraline/toremifene, sertraline/bepridil, and amodiaquine/clomiphene. Conclusions: Our study shows the feasibility of identifying pairs of approved drugs that synergistically block Ebola virus infection in cell cultures. We discuss our findings in terms of the theoretic ability of these or alternate combinations to reach therapeutic levels. Future research will assess selected combinations in small-animal models of Ebola virus disease.
Background: A need to develop therapeutics to treat Ebola virus diseasepatients in remote and resource-challenged settings remains in the wake of the 2013-2016 epidemic in West Africa. Toward this goal, we screened drugs under consideration as treatment options and other drugs of interest, most being small molecules approved by the Food and Drug Administration. Drugs demonstrating in vitro antiviral activity were advanced for evaluation in combinations because of advantages often provided by drug cocktails. Methods: Drugs were screened for blockade of Ebola virus infection in cultured cells. Twelve drugs were tested in all (78 pair-wise) combinations, and 3 were tested in a subset of combinations. Results: Multiple synergistic drug pairs emerged, with the majority comprising 2 entry inhibitors. For the pairs of entry inhibitors studied, synergy was demonstrated at the level of virus entry into host cells. Highly synergistic pairs included aripiprazole/piperacetazine, sertraline/toremifene, sertraline/bepridil, and amodiaquine/clomiphene. Conclusions: Our study shows the feasibility of identifying pairs of approved drugs that synergistically block Ebola virus infection in cell cultures. We discuss our findings in terms of the theoretic ability of these or alternate combinations to reach therapeutic levels. Future research will assess selected combinations in small-animal models of Ebola virus disease.
Authors: Lisa M Johansen; Lisa Evans DeWald; Charles J Shoemaker; Benjamin G Hoffstrom; Calli M Lear-Rooney; Andrea Stossel; Elizabeth Nelson; Sue E Delos; James A Simmons; Jill M Grenier; Laura T Pierce; Hassan Pajouhesh; Joseph Lehár; Lisa E Hensley; Pamela J Glass; Judith M White; Gene G Olinger Journal: Sci Transl Med Date: 2015-06-03 Impact factor: 17.956
Authors: Xuelian Zhao; Katie A Howell; Shihua He; Jennifer M Brannan; Anna Z Wec; Edgar Davidson; Hannah L Turner; Chi-I Chiang; Lin Lei; J Maximilian Fels; Hong Vu; Sergey Shulenin; Ashley N Turonis; Ana I Kuehne; Guodong Liu; Mi Ta; Yimeng Wang; Christopher Sundling; Yongli Xiao; Jennifer S Spence; Benjamin J Doranz; Frederick W Holtsberg; Andrew B Ward; Kartik Chandran; John M Dye; Xiangguo Qiu; Yuxing Li; M Javad Aman Journal: Cell Date: 2017-05-18 Impact factor: 41.582
Authors: Wei Sun; Shihua He; Carles Martínez-Romero; Jennifer Kouznetsova; Gregory Tawa; Miao Xu; Paul Shinn; Ethan Fisher; Yan Long; Omid Motabar; Shu Yang; Philip E Sanderson; Peter R Williamson; Adolfo García-Sastre; Xiangguo Qiu; Wei Zheng Journal: Antiviral Res Date: 2016-11-24 Impact factor: 5.970
Authors: Etienne Gignoux; Andrew S Azman; Martin de Smet; Philippe Azuma; Moses Massaquoi; Dorian Job; Amanda Tiffany; Roberta Petrucci; Esther Sterk; Julien Potet; Motoi Suzuki; Andreas Kurth; Angela Cannas; Anne Bocquin; Thomas Strecker; Christopher Logue; Thomas Pottage; Constanze Yue; Jean-Clement Cabrol; Micaela Serafini; Iza Ciglenecki Journal: N Engl J Med Date: 2016-01-07 Impact factor: 91.245
Authors: Gibrilla F Deen; Nathalie Broutet; Wenbo Xu; Barbara Knust; Foday R Sesay; Suzanna L R McDonald; Elizabeth Ervin; Jaclyn E Marrinan; Philippe Gaillard; Ndema Habib; Hongtu Liu; William Liu; Anna E Thorson; Francis Yamba; Thomas A Massaquoi; Faustin James; Archchun Ariyarajah; Christine Ross; Kyle Bernstein; Antoine Coursier; John Klena; Marylin Carino; Alie H Wurie; Yong Zhang; Marion S Dumbuya; Neetu Abad; Baimba Idriss; Teodora Wi; Sarah D Bennett; Tina Davies; Faiqa K Ebrahim; Elissa Meites; Dhamari Naidoo; Samuel J Smith; Patricia Ongpin; Tasneem Malik; Anshu Banerjee; Bobbie R Erickson; Yongjian Liu; Yang Liu; Ke Xu; Aaron Brault; Kara N Durski; Jörn Winter; Tara Sealy; Stuart T Nichol; Margaret Lamunu; James Bangura; Sihem Landoulsi; Amara Jambai; Oliver Morgan; Guizhen Wu; Mifang Liang; Qiudong Su; Yu Lan; Yanzhe Hao; Pierre Formenty; Ute Ströher; Foday Sahr Journal: N Engl J Med Date: 2015-10-14 Impact factor: 91.245
Authors: Murat Cokol; Hon Nian Chua; Murat Tasan; Beste Mutlu; Zohar B Weinstein; Yo Suzuki; Mehmet E Nergiz; Michael Costanzo; Anastasia Baryshnikova; Guri Giaever; Corey Nislow; Chad L Myers; Brenda J Andrews; Charles Boone; Frederick P Roth Journal: Mol Syst Biol Date: 2011-11-08 Impact factor: 11.429
Authors: Stephen D S McCarthy; Beata Majchrzak-Kita; Trina Racine; Hannah N Kozlowski; Darren P Baker; Thomas Hoenen; Gary P Kobinger; Eleanor N Fish; Donald R Branch Journal: PLoS Negl Trop Dis Date: 2016-01-11
Authors: Peter B Madrid; Sidharth Chopra; Ian D Manger; Lynne Gilfillan; Tiffany R Keepers; Amy C Shurtleff; Carol E Green; Lalitha V Iyer; Holli Hutcheson Dilks; Robert A Davey; Andrey A Kolokoltsov; Ricardo Carrion; Jean L Patterson; Sina Bavari; Rekha G Panchal; Travis K Warren; Jay B Wells; Walter H Moos; Raelyn L Burke; Mary J Tanga Journal: PLoS One Date: 2013-04-05 Impact factor: 3.240
Authors: Stylianos Bournazos; David J DiLillo; Arthur J Goff; Pamela J Glass; Jeffrey V Ravetch Journal: Proc Natl Acad Sci U S A Date: 2019-09-04 Impact factor: 11.205
Authors: C E Hulseberg; L Fénéant; K M Szymańska-de Wijs; N P Kessler; E A Nelson; C J Shoemaker; C S Schmaljohn; S J Polyak; J M White Journal: J Virol Date: 2019-04-03 Impact factor: 5.103
Authors: Jinwoo Lee; Alex J B Kreutzberger; Laura Odongo; Elizabeth A Nelson; David A Nyenhuis; Volker Kiessling; Binyong Liang; David S Cafiso; Judith M White; Lukas K Tamm Journal: Nat Struct Mol Biol Date: 2021-01-18 Impact factor: 15.369
Authors: Kai J Rogers; Olena Shtanko; Laura L Stunz; Laura N Mallinger; Tina Arkee; Megan E Schmidt; Dana Bohan; Bethany Brunton; Judith M White; Steve M Varga; Noah S Butler; Gail A Bishop; Wendy Maury Journal: J Leukoc Biol Date: 2020-05-22 Impact factor: 4.962